Silke Zeschke

Impact of High-Risk Cytogenetics and Achievement of Molecular Remission on Long-Term Freedom from Disease after Autologous–Allogeneic Tandem Transplantation in Patients with Multiple Myeloma

Nicolaus Kröger, Anita Badbaran, Tatjana Zabelina et al. · Biology of Blood and Marrow Transplantation · 2012 · 88 citations · Full text

Medicine, Oncology, Chemotherapy +16

Post-transplant immunotherapy with donor-lymphocyte infusion and novel agents to upgrade partial into complete and molecular remission in allografted patients with multiple myeloma

Nicolaus Kröger, Anita Badbaran, Michael Lioznov et al. · Experimental Hematology · 2009 · 86 citations

Life Sciences, Immunology, Oncology +17

Axicabtagene ciloleucel in vivo expansion and treatment outcome in aggressive B-cell lymphoma in a real-world setting

Francis Ayuk, Carolina Berger, Anita Badbaran et al. · Blood Advances · 2021 · 45 citations · Full text

Life Sciences, Hematology, Oncology +17

Chimerism studies with quantitative real-time PCR in stem cell recipients with acute myeloid leukemia

Bettina Wiedemann, Evgeny Klyuchnikov, Nicolaus Kröger et al. · Experimental Hematology · 2010 · 33 citations

Medicine, Hematology, Molecular Biology +13

Molecular monitoring of T-cell kinetics and migration in severe neurotoxicity after real-world CD19-specific chimeric antigen receptor T cell therapy

Susanna Carolina Berger, Boris Fehse, Nuray Akyüz et al. · Haematologica · 2022 · 27 citations · Full text

Life Sciences, Immunology, Neuroscience +17